New rapid test for bloodstream infections in the hospital
Part of Infections clinical trials.
This trial tests a new rapid blood test (Cobas Eplex) that may help doctors identify the cause of a bloodstream infection faster than standard methods. If you are an adult or child hospitalized for a blood infection, this study could lead to quicker, more targeted treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a blood infection that started while you were in the emergency room or a general hospital ward
- You stayed in the hospital for at least one full day after your blood draw
- If you are a child (under 18), the infection must be caused by a specific type of bacteria (gram-negative)
- You have not had a positive blood culture in the last 14 days
- The bacteria in your blood is not thought to be a contaminant from your skin or the environment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick DNA-based test to find bloodstream infections in ICU patients. If you are getting standard blood cultures for a suspected infection, you may be able to join.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This study gathers information about blood infections to better understand them and improve care. It may help by providing detailed data on your specific infection.
This trial tests a new, faster way to find bacteria in the blood of children with suspected sepsis. It uses a molecular test that may give results sooner than standard cultures, helping doctors treat infections more quickly.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
Hear when a new Bloodstream Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.